...
ENSGLARGE

The Ensign Group, Inc.

HealthcareMedical - Care Facilities
$214.17
$0.02(+0.71%)
52W$118.73
$217.00
FinancialsValuationvs EHC
Updated Mar 3, 12:00 AM
RSI67
RS Rating78/99
Beta0.43
Volatility28%
F-Score7/9
Mkt Cap$12.4B
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

The Ensign Group, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is moderate (RS Rating: 78), indicating performance broadly in line with the market. Earnings growth of 6% provides fundamental context to the price action. Momentum will need to be maintained above the 50-day moving average to sustain this leadership phase.

Relative Strength
78
out of 99
Average
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
0.43
vs S&P 500
LOW VOL
52W Position
97%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$186.77
50 SMA > 100 SMA$183.62
100 SMA > 150 SMA$177.89
150 SMA > 200 SMA$170.34

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$201.87+6.10%ABOVE
50 SMA$186.76+14.67%ABOVE
100 SMA$183.62+16.64%ABOVE
150 SMA$177.89+20.39%ABOVE
200 SMA$170.34+25.73%ABOVE

Price Performance

1D+0.7%
1W+0.0%
1M+24.7%
3M+15.4%
6M+24.1%
YTD+23.1%
1Y+65.8%
3Y+33.8%
52-Week Trading Range97% from low
$214.17
52W Low$118.73
52W High$217.00

Technical Indicators

RSI (14)BULLISH
66.7
305070
VCP ScoreHOT
7/10
Base depth: 23.1%

Risk Profile

Beta
0.43
52W Vol
28%
ATR
$6.45
Max DD (1Y)
-13%

Volume Analysis

Today
214
50D Avg
332.8K
Vol Ratio
0.00x
Liquidity
LIQUID

Earnings Momentum

Q4'24+258%
$1.36
Q1'25+15%
$1.37
Q2'25+18%
$1.44
Q3'25+6%
$1.42
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+14.19%
5 Years:+16.05%
3 Years:+18.68%
TTM:+17.54%

Compounded Profit Growth

10 Years:+18.61%
5 Years:+13.80%
3 Years:+13.92%
TTM:+35.35%

Stock Price CAGR

10 Years:+27.29%
5 Years:+20.81%
3 Years:+33.77%
1 Year:+65.83%

Return on Equity

10Y Avg:16.8%
5Y Avg:18.2%
3Y Avg:16.7%
Last Year:15.5%

Key Metrics

Market Cap$12.4B
Gross Margin20.5%
Net Margin6.8%
Piotroski F-Score7/9

More ENSG Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

ENSG vs EHCEHCBKDNHCSEM

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 78 meansENSG outperformed 78% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.43 means 57% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 7/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 7/10 with HOT status.

Frequently Asked Questions

Is ENSG in an uptrend right now?

ENSG has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, ENSG is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is ENSG overbought or oversold?

ENSG's RSI (14) is 67. The stock is in neutral territory, neither overbought nor oversold.

Is ENSG outperforming the market?

ENSG has a Relative Strength (RS) Rating of 78 out of 99. ENSG is performing about average compared to the market.

Where is ENSG in its 52-week range?

ENSG is trading at $214.17, which is 99% of its 52-week high ($217.00) and 97% above its 52-week low ($118.73).

How volatile is ENSG?

ENSG has a Beta of 0.43 and 52-week volatility of 28%. It's less volatile than the S&P 500 - generally more stable.